Why is breast cancer so poorly conducted in developing countries

Breast cancer is on the rise in developing countries and mortality. Now, a consensus around the world, published in this issue of the Lancet Oncology, has identified the biggest challenges for solutions to improve the results corresponding to diagnosis and treatment of breast cancer in countries with low income and middle income (LMCs) and resource review of cancer experts. In countries with low income is little awareness that breast cancer treatable, insufficient pathology services for diagnosis and staging and poor treatment availability, especially for radiation therapy and drug treatments, is for decreasing breast cancer mortality are required.

In Middle resource countries are the main challenges of late-stage presentation of the disease, limited poor provision of Community data collection, access to early detection, diagnosis and treatment, and low prioritization of the breast cancer control programmes in the health care system.

Cancer incidence and mortality by 50% between 2002 and 2020 to increase is expected to be around the world. This global cancer rates will be rising most in developing countries. Up to 2020, 70% of prostate cancers are expected to be 16 million year in LMCs. As the most common cause of cancer deaths among women around the world breast cancer results as Foundation for the foreseeable global cancer epidemic to fend off must be proactive.

To improve the mortality rates in resource-poor countries, the chest has health global initiative (BHGI) resource-sensitive, evidence-based clinical guidelines produced for the early detection, diagnosis and treatment of breast cancer in the LMCs. This review by Benjamin O. Anderson, Fred Hutchinson Cancer Research Center and University of Washington, Seattle, United States, and colleagues in cancer centres worldwide, sums up the results BHGI Summit on international breast health global consensus of the fourth held in Chicago, ILUSA, June 9-11, 2010, which brought together more than 150 experts from 43 countries.

The Panel discussions and delegates reports were bundled this consensus analysis form. In LMCs, a lack of awareness about cancer or the inability to look for primary care, means that patients is often present with late-stage disease. In India, for example, 50% - have 70% of locally advanced or metastatic disease at diagnosis. The authors say "While four out of five cases of breast cancer in the United States and Western Europe are cured breast cancer probably is a death sentence in most sub-Saharan African countries,".

Doctors in the developing countries are often not well trained in diagnosis and treatment may be either not available or too expensive to afford for patients (health financing payments are in the poorest countries of the world highest). Healthcare professionals in LMCs have may not be sufficient training in surgical techniques such as mastectomy, which means that malignant tissue in the body is left. After surgery, patients fail, received the critical drug therapies, the metastases can prevent that established. The reason are combined these factors that are so high breast cancer mortality in LMCs.

Public awareness about breast cancer women is very low in most LMCs. techniques know not of self-examination often do healthcare professionals educate them on these issues. In the poorest settings the doctors themselves have never seen an early breast cancer case, and therefore may not need, diagnosis and treatment see in these early, potentially curable to initiate phase.

The authors say: "LMCs healthcare systems are several challenges including national or regional data collection, infrastructure and capacity (including appropriate equipment and drug acquisitions and professional training and accreditation), the need for the qualitative and quantitative research to support decision-making, and strategies to improve the access of patients and compliance and public", Members of the health professionals and politicians aware that breast cancer is a low-cost, treatable disease. "

They conclude: "Differences exist between and within countries, that to understand a need for close subpopulations within each country or region to optimize such as breast cancer care for underserved women around the world."

Source code
The Lancet Oncology